In addition to his clinical practice, Dr. Faridar holds an academic appointment as Associate Professor of Neurology at Houston Methodist Weill Cornell Medical College and is a member of the Houston Methodist Research Institute. His research integrates immune mechanisms, neuroimaging biomarkers, and translational therapeutics in neurodegenerative disease, and he has contributed to multiple high‑impact studies examining brain inflammation, tau pathology, and immune‑modulating interventions in Alzheimer’s disease and related disorders. Through his combined clinical and research efforts, Dr. Faridar plays a key role in advancing precision diagnostics and mechanism‑driven treatments for cognitive and neurodegenerative conditions. He Co-Leads the Biomarker Core with Dr. Soto and will coordinate overall activities of the Core and will be responsible for all the studies of inflammation markers.
As Co-Lead of the Biomarker Core, Dr. Faridar provides critical strategic and operational oversight for the Core’s multidisciplinary initiatives. He is responsible for the coordination of all Core activities and serves as the primary investigator for the inflammatory marker studies. By bridging his expertise in patient care with mechanism-driven research, Dr. Faridar ensures that the Core’s biomarker discovery and validation efforts are rigorously aligned with clinical outcomes and the advancement of precision diagnostics for neurodegenerative conditions.